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Abstract 
BACKGROUND: Reducing maternal mortality is one of the targets in the Millennium Development Goals (MDGs). 
In a systematic review, 4.6 per cent (95% CI 2.7-8.2) of pregnancies were complicated by preeclampsia 
worldwide. Preeclampsia occurs in around 10% of pregnancies in the world whereas developing countries 
contribute more than developed countries. In developing countries, there are 13 cases of preeclampsia in every 
1,000 births, whereas in developed countries only 2-3 cases of preeclampsia are found in every 10,000 deliveries. 
Variations in prevalence among countries reflect, at least in part, differences in the distribution of maternal age 
and the proportion of nulliparous pregnant women in the population. 
AIM: We aimed to investigate the role of placental growth factor, soluble endoglin, and uterine artery diastolic 
notch to predict the early onset of preeclampsia. 
METHODS: This study used an analytical study with a nested case-control design. The study was conducted at 
Bunda Thamrin Hospital, Tanjung Mulia Mitra Medika Hospital, Sundari Hospital and a private clinic, from March 
to November 2018 with a total sample of 70 research subjects. 
RESULTS: Uterine artery diastolic notch was not found in 50% of subjects. A total of 27 subjects (38.6%) had a 
unilateral diastolic notch, and 8 subjects (11.4%) had a bilateral diastolic notch. Cut-off point PIGF levels was 441 
pg/ml, and Area Under Curve (AUC) 82.5% (95% CI 61.5%-100%), with sensitivity 80% and specificity 87.7%. 
The levels sEng in this study could not predict the incidence of early-onset preeclampsia (p = 0.113). Combined 
PlGF and pulsatile index of uterine arteries may predict early onset preeclampsia with sensitivity 40% and 
specificity 90.77%. From these results, pregnant women o 22-24 weeks of pregnancy, the levels of PlGF and the 
uterine artery pulsatility index can be a predictor of early-onset preeclampsia. Examination of PlGF levels alone is 
sufficient as a predictor of early-onset preeclampsia. 
CONCLUSION: From these results, it can be concluded that in pregnant women of 22-24 weeks, the diastolic 
notches in uterine arteries cannot predict the incidence of early-onset preeclampsia. PlGF levels and pulsatile 
index of uterine arteries can be used as predictors of early-onset preeclampsia although examination of PlGF 
levels alone is sufficient as a predictor of early-onset preeclampsia. 
 
 
Introduction 
 
According to the American Family Association 
dividing the number of risk factors for Preeclampsia in 
3 (three) groups, namely pregnancy-related factors, 
maternal factors and paternal factors. Maternal factors 
are more biologically maternal, including age, parity, 
race, history of preeclampsia, history of hypertension 
and so on. Also, many theories suggest that the 
pathogenesis of preeclampsia is related to the 
placentation process, but to date, the pathogenesis of 
preeclampsia is still unclear. Because the 
multifactorial pathogenesis of the pre-eclampsia 
phenotype is unexplained, prevention and prediction 
are still unknown, treatment of clinical symptoms must 
be the main thing in preventing maternal morbidity 
and mortality [1].
 
In preeclampsia, trophoblast invasion and 
velocimetry doppler can detect quantitative and 
qualitative changes in uterine arteries in waveform. In 
Doppler velocimetry, it can be seen the blood flow in 
the uterine artery, arcuate, radial and spiral around 
the trophoblast tissue, so that measurements can be 
made on the various indices needed [2], [3].
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uterine artery wave appearance in the first trimester of 
pregnancy has a diastolic notch that disappears after 
24 weeks of pregnancy. If the picture of this curve 
persists and the PI and RI values remain high after a 
pregnancy of 20-24 weeks, it means that there is high 
pressure in the uterine arteries which will usually 
result in preeclampsia or stunted fetal growth [4].
 
Endothelial dysfunction leads to progressive tissue 
and multiorgan damage to the mother and fetus. song 
is a dissolved form of a surface co-receptor 
transforming growth factor (TGF-β1 and TGF-β3) 
expressed on endothelial cells and 
syncytiotrophoblasts. It modulates the work of TGF-β1 
and TGF-β3 which play an important role in vascular 
homeostasis. Concentration increases when placental 
perfusion is poo so that that serum levels can act as 
markers of changes in the impedance of the 
uteroplacental circulation [1], [5].
 
We aimed to investigate the role of placental 
growth factor, soluble endoglin, and uterine artery 
diastolic notch to predict the early onset of 
preeclampsia. 
 
 
 
Methods  
 
This study used an analytical study with a 
nested case-control design. The study was conducted 
at Bunda Thamrin Hospital, Tanjung Mulia Mitra 
Medika Hospital, Sundari Hospital and a private clinic, 
from March to November 2018 with a total sample of 
70 research subjects. 
 
 
Results 
 
The research followed by 70 pregnant women 
with gestational age 22-24 The week came to Bunda 
Thamrin Hospital, Tanjung Mulia Mitra Medika 
Hospital, Sundari Hospital and private practice that 
had fulfilled the inclusion and exclusion criteria.  
Table 1: Demographic Characteristics of Research Subjects 
Characteristics of Subjects n = 70 
Age of Pregnancy, n (%)  
22 weeks 22 (31.4) 
23 weeks 13 (18.6) 
24 weeks 35 (50) 
BMI, mean (SD), kg/m
2 
24.47 (4.02) 
Parity, n (%)  
Primigravida 31 (44.3) 
Second Gravida 23 (32.9) 
Multigravidas 16 (22.9) 
 
Subjects with 24 weeks' gestation were the 
most subjects with a total of 35 people (50%). A total 
of 31 subjects (44.3%) were primigravida.  
Table 2: Diastolic Notch Examination Results on Right and Left 
Uterine artery 
Uterine Diastolic Notch, n (%) n = 70 
Without Diastolic Notch 35 (50) 
Unilateral Diastolic Notch 27 (38.6) 
Bilateral Diastolic Notch 8 (11.4) 
 
Using ultrasound, it is known that as many as 
50% of subjects have the one without the dichotomy. 
A total of 27 subjects (38.6%) had a unilateral diastolic 
notch, and 8 subjects (11.4%) had a bilateral diastolic 
notch.  
Table 3: Results of Uterine artery Examination, Placental 
Growth Factor (PlGF) Level, and soluble Endoglin (sEng) level 
 Uterine A. PlGF sEng 
Mean 1.14 834.21 5.37 
SD 0.36 413.75 1.99 
Minimum  0.44 165 2.66 
Maximum 2 , 08 2097 12.68 
CI 95%  1.05-1.22 735.56 - 932.87 4.90 - 5.85 
 
The results of the mean examination A. 
Female is 1.14 with SD = 0.36 with the lowest level 
was 0,44 and highest 2.08. PlGF is 834.21 with SD = 
413.75, with the lowest level of 165 and the highest of 
2097. The mean level of the sEng is 5.37 with SD = 
1.99 with the lowest level of 2.66 and the highest 
12.68. 
Table 4: The incidence of Early Onset Preeclampsia 
Preeclampsia n = 70 
 Normal 65 (92.9) 
 Preeclampsia (proteinuria + 3) 2 (2.9) 
 Preeclampsia (proteinuria + 4) 3 (4.3) 
 
From the results of monitoring of all subjects 
during the study, it was found that there were 65 
subjects (92.9%) did not experience preeclampsia, 2 
subjects (2.9%) had preeclampsia (proteinuria +3) and 
3 subjects (4.3%) with preeclampsia (proteinuria +4). 
Table 5: The difference of PlGF and sEng level between 
Subjects with Diastolic Notch and Without Diastolic Notch 
 Uterine Diastolic Notch P 
+ (n = 35) (n = 35) 
IP a. Uterina, mean (SD) 1.42 (0.26) 0.85 (0.17) < 0.001
a 
PlGF, mean (SD) 695.6 (385.69) 972.83 (398.88) 0.004
a 
sEng , mean (SD) 5.44 (2.39) 5.30 (1.51 0.533
b
 
a
T Independent; 
b
Mann Whitney. 
 
Mean A. uterina levels in subjects with 
diastolic notch group was 1.42 (SD = 0.26) while the 
mean A. uterina in the group without diastolic notch 
was 0.85 (SD = 0.17). Using the Independent T-test 
showed that there was a significant difference in 
uterine artery levels between subjects with diastolic 
notch and without diastolic notch (p < 0.001). The 
mean PlGF level in the group of subjects with a 
diastolic notch was 695.6 (SD = 385.69) while the 
mean of PlGF in the group without diastolic notch 
subjects was 972.83 (SD = 398.88). Using the 
Independent T-test showed that there was a 
significant difference in PLGF between subjects with 
diastolic notch and without diastolic notch (p = 0.004). 
The mean level in subjects in the diastolic notch group 
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was 5.44 (SD = 2.39) while the mean level in the 
group without diastolic notch subjects was 5.30 (SD = 
1.51) using the Mann Whitney test indicating that 
there were differences in the mean sEng significant 
between subjects with diastolic notch and without 
diastolic notch (p = 0.533). 
 
Figure 1: Boxplot Graph of PI Differences a. uterina in subjects with 
diastolic notch and without diastolic notch 
 
There were no subjects over the age of 35 
who had early onset preeclampsia, while there were 5 
people (8.1%) subjects aged ≤ 35 years had 
preeclampsia. The results of the analysis using 
Fischer's exact test showed that no significant 
association was found between age and the incidence 
of early-onset preeclampsia (p = 1.000).  
 
Figure 2: Boxplot graph differences in uterine arterial PlGF levels in 
subjects with diastolic notch and without diastolic notch 
 
From the 31 subjects with primigravida 
pregnancies, there were only 3 subjects (9.6%) who 
had early onset preeclampsia, while there were 2 
more samples with early-onset preeclampsia found in 
women with multigravida pregnancy. The results of 
the analysis using Fischer's exact test showed that 
there was no significant relationship between maternal 
parity and the incidence of early-onset preeclampsia 
(p = 0.251). 
From the 32 subjects who had overweight and 
obesity BMI, there was only 1 subject (3.1%) who had 
early onset preeclampsia, while there were 4 people 
(14.8%) subjects with underweight and normoweight 
who had preeclampsia. The results of the analysis 
using Fischer's exact test showed that there was no 
significant relationship between BMI and the incidence 
of early-onset preeclampsia (p = 0.169). 
 
Figure 3: Boxplot graph of levels of difference in subjects with 
diastolic notch and without diastolic notch 
 
From the 35 subjects who had uterine artery 
diastolic notch, there were 5 subjects (14.3%) who 
had early onset preeclampsia, while no preeclampsia 
was found in a subject that did not have a diastolic 
notch. The results of the analysis using Fischer's 
exact test showed that no significant association was 
found between uterine artery diastolic notch and the 
incidence of early-onset preeclampsia (p = 0.054).  
Table 6: Relationship of Age, Parity, BMI, Diastolic Notch, PlGF 
level and sEng level early onset of preeclampsia  
 Preeclampsia p 
+ (n = 5) - (n = 65) 
Age,n (%)   
 
> 35 years old 0 8 (100) 1.000
a 
≤ 35 years old 5 (8.1) 57 (91.9) 
 
Parity   
 
Primigravida 3 (9.6) 28 (90.4) 
 
Secundi Gravida 0 23 (100) 0.251
a 
Multigravida 2 (12.5) 14 (87.5) 
 
BMI, n (%)   
 
Overweight dan Obese 1 (3.1) 31 (96.9) 0.169
a 
Underweight dan Normoweight 4 (14.8) 23 (85.2) 
 
Diastolic Notch    
 
Found 5 (14.3) 30 (85.7) 0.054
a 
Not found 0 35 (100)  
PI mean (SD) 1.44 (0.30) 1.11 (0.35) 0.045
b 
PlGF, mean (SD) 411 (301.67) 866.77 (404.73) 0.016
c 
sEng, mean (SD) 8 (4.11) 5.17 (1.62) 0.113
c 
Fischer'
s Exact; 
b
T Independent; 
c
Mann Whitney. 
  
The mean PI uterine artery in early-onset 
preeclampsia subjects was lower with a mean of 1.44 
(SD = 0.30) compared to subjects who did not 
experience preeclampsia with a mean of 1.11 (SD = 
0.35). Using the Mann Whitney test showed that there 
were differences in the mean PI uterine artery 
between subjects with preeclampsia and those 
without preeclampsia (p = 0.045). 
The mean PlGF in early-onset preeclampsia 
subjects was lower with a mean of 411 (SD = 301.67) 
than subjects who did not experience preeclampsia 
with a mean of 866.77 (404.73). Using the Mann 
Whitney test showed that there were differences in the 
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mean PLGF levels between subjects with 
preeclampsia and those without preeclampsia (p = 
0.016). 
 The mean score in subjects with early-onset 
preeclampsia was seen to be higher with a mean of 8 
(SD = 4.11) than subjects without preeclampsia with a 
mean of 5.17 (1.62). Using the Mann Whitney test 
showed that there was no difference in mean levels 
between subjects with preeclampsia and those 
without preeclampsia (p = 0.113). 
 
Pulsality Index of Uterine Artery 
Analysis showed that the ROC curve obtained 
a value of p = 0.037 which means that uterine artery 
IP in this study can predict the incidence of early-
onset preeclampsia Area Under Curve (AUC) of 
78.2% (95% IK 59.3% - 97%). 
 
Figure 4: ROC curve of uterine artery IP against preeclampsia 
 
Based on sensitivity and specificity curves in 
Figure 5, the Cut Off value for uterine arterial IP is 
obtained as 1,228. By using cut-off points 1,228, the 
uterine artery IP sensitivity value was 80%, and the 
specificity was 64.6%.  
 
Figure 5: Uterine Arterial IP sensitivity (blue) and specificity (green) 
curve for the incidence of early-onset preeclampsia 
 
PIGF 
From the analysis using the ROC curve the 
value p = 0.016 means that PlGF in this study can 
predict the incidence of early onset preeclampsia with 
a value of Area Under Curve (AUC) 82.5% (95% IK 
61.5% - 100%). 
 
Figure 6: ROC Curve of PlGF against Preeclampsia 
 
Based on the sensitivity and specificity curves 
in Figure 7, the Cut Off value for PlGF levels is 
obtained by 441. By using the cutoff point 441, the 
sensitivity value of PlGF is 80%, and the specificity is 
87.7%.  
 
Figure 7: Curve sensitivity (blue) and specificity (green) of PlGF of 
genesis early-onset preeclampsia 
 
sEng 
From the results of analysis using ROC 
curves obtained by value p = 0,113 which means that 
sEng in this study could not predict the incidence of 
early-onset preeclampsia. 
 
Figure 8. ROC Curves of Preeclampsia 
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Discussion 
 
The research followed by 70 pregnant women 
aged 22-24 weeks who came to the Bunda Thamrin 
Hospital, Tanjung Mulia Mitra Medika Hospital, 
Sundari Hospital and private clinic that had met the 
inclusion criteria and exclusion. Pregnant women who 
collected a mean age of < 35 years (88.5%) 
dominated this study, with a mean Body Mass Index 
of 24.47 kg/m
2 
(overweight). Subjects with 24 weeks' 
gestation were the most subjects with a total of 35 
people (50%). A total of 31 subjects (44.3%) were 
primigravida who is one risk factor for early-onset 
preeclampsia. While the age of pregnant women > 35 
years and nutritional conditions of women in 
overweight or obese conditions are a risk factor for the 
occurrence of late-onset preeclampsia, although this 
study still records the characteristics of the sample 
state [29].
 
Table 7: Sensitivity, specificity, the positive and negative 
predictive value of PI Uterine artery and PlGF level of Early-
onset Preeclampsia 
 Preeclampsia Sensitivity Specificity NPP NPN 
Positive Negative 
IP.  
Uterina A.  
1,228 4 2223 80% 64.6% 14., 8 97.7% 
<1,228 1 42     
PlGF ≤ 441 4 8 80% 87.7% 33.3% 98.3% 
> 441 1 57     
PlGF + IP Uterina A. 40% 90.77% 25% 95.16% 
 
A total of 27 subjects (38.6%) had a unilateral 
diastolic notch, and 8 subjects (11.4%) had a bilateral 
diastolic notch. But this does not make the reference 
value a predictor of the incidence of early-onset 
preeclampsia. Different analytical methods are used 
to measure the reference value. Several other studies 
also included ultrasound examinations with the 
presence of diastolic notch, Kushtagi & Emani, 2016 
found 38 patients with diastolic notch diagnosed with 
preeclampsia from a total of 48 patients with 
preeclampsia, Vartun, Flo, Widnes, & Acharya, 2016 
found 23 samples with diastolic notch from 27 
samples [6], [7].
 
Different studies have found that the mean 
PLGF level in preeclampsia is following 125 pg/ml at 
gestational age 20-37 weeks [8]: 95 pg/ml at 
midtrimester gestational age [9]; 38.7 pg/ml at 32-37 
weeks gestation [10]; 54 pg/ml at 20-34 weeks 
gestation [11]; 83.75 pg/ml at 20-30 weeks gestation 
[12]; 239.75 pg/ml at 25-40 weeks’ gestation [13].  
The mean level sEng in this study was 8.0 
ng/ml at 22-24 weeks' gestation. In other studies it can 
be found that the mean serum level in preeclampsia is 
53.3 ng/ml at gestational age less than 34 weeks [14]; 
11.08 ng/ml at gestational age 19-24 weeks [15]; 60.9 
ng/ml during the first and second trimester of 
pregnancy [16]; 69.2 ng/ml at the third trimester of 
pregnancy [17]
 
11.58 ng/ml at gestational age less 
than 37 weeks [18]. 
 
Diastolic Notch and the incidence of Early 
Onset Preeclampsia  
From the 35 samples of pregnant women who 
had a diastolic notch, it was found that there were 5 
samples experiencing early-onset preeclampsia, with 
a p-value of 0.054 (> 0.05) that did not have a 
significant relationship, this was probably due to the 
number of samples there are still a few who have 
preeclampsia. 
Other studies also found that there were 
significant differences between patients with normal 
pregnancies and patients with pregnancy who 
experienced preeclampsia, namely the study of 
Vartun, Flo, Widnes, & Acharya, 2016 with a p-value < 
0.0001 (p < 0.05) very meaningful by finding 23 
patients with diastolic notch who had preeclampsia 
compared to 4 patients with diastolic notch as well but 
not preeclampsia [19].
 
 
Mean Pulsatility Index of Uterine Artery for 
the Incidence of Early Onset Preeclampsia  
Mean of IP uterine artery in subjects with 
early-onset preeclampsia seen higher with a mean of 
1.44 (SD = 0.30) than subjects who did not experience 
preeclampsia with a mean of 1.11 (0.35) with a p-
value of 0.045 which means that it has a significant 
value to distinguish cases preeclampsia. From the 
previous research studies, it was also dominated by 
significant results that were in line with this study, 
which made the first step to conduct a non-invasive 
screening. Other studies by (Vartun, Flo, Widnes, & 
Acharya, 2016), (Yu, Cui, Chen, & Chang, 2017), and 
(Narang, Agarwal, Das, Pandey, Agrawal, & Ali, 2016) 
with p-value very significant < 0,0001 was performed 
in early trimester pregnant women who ended 
preeclampsia [19], [20], [21].
 
 
PlGF and incidence of Early Preeclampsia 
Previous studies have also been conducted 
by Bian, Shixia, & Duan, 2015 which showed a 
significant difference in the decrease in PLGF levels in 
preeclampsia performed in first trimester pregnant 
women with an mean of 115.72 pg/ml compared to 
control 217.30 pg/ml (p-value < 0.001) [22]; and by 
Gannoun, et al., in the following year (2016) which 
conducted a more in-depth study which divided based 
on gestational intervals with all the results of research 
on PlGF levels found to be significant at 24-29 weeks 
the PlGF mean levels were 58.62 pg./ml which ends 
early-onset preeclampsia (p-value 0.007) [21].
 
 
sEng on the incidence of Early Awakening 
Preeclampsia 
From the results of this study, the p-value of 
0.113 was found to be not significantly different 
between the levels of Sickness in early onset 
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preeclampsia with a mean value of 8 ng/ml in 
preeclampsia which was slightly higher than the mean 
in control, ie 5.17 ng/ml. In various studies, there are 
still various levels of sEng which have not yet become 
standard, as according to EL-Said, Mohammed, EL-
Ashrawi, & Saad, 2013 the mean sEng levels in 
preeclampsia also increased (11.06 ng/ml) compared 
to the mean control (5, 92 ng/ml) but with p-value < 
0.01 which means significant differences were found 
[22]. Equally with Perucci's research, 2014 which 
found that there was an increase in serum levels in 
preeclampsia, both early and late onset with a p-value 
of 0.001 [23]. Research by Masuyama, Nakatsukasa, 
Takamoto, & Hiramatsu, 2007 for very different levels 
of pre-eclampsia, ie 60.9 ng/ml with controls 11.2 
ng/ml (p-value < 0.01) [24]. Although there are 
significant results from various studies above, there 
are other studies that are also not significantly 
different as significant as in this study, according to 
KEDuhig, 2015 with a p-value of 0.058 (p-value > 
0.05) which was carried out examination in women the 
second trimester of pregnancy was found to have a 
mean level of 2.78 ng/ml which was lower than the 
control of 3.52 ng/ml but in the sample of other 
pregnant women in the third trimester of pregnancy 
who were also carried out in this study found 
significant results (p-value 0.001 ) [25].
 
The results of the study showed that the 
mean serum soluble endoglin (sEng) of mothers with 
Early Onset Preeclampsia was 41.47 ± 13.88 ng/ml 
while lower in Late-Onset Preeclampsia 33.19 ± 15.99 
ng/ml. 
 
 
Predictors of Early Onset preeclampsia 
Based on bivariate data obtained significant 
results from a variety of predictor variables early-onset 
preeclampsia, which are detailed in the previous 
chapter with the following conclusion: 
Table 8: Predictors of Early Onset Preeclampsia 
 Area Under 
the Curve 
p cut off point 
IP uterine artery 78.2% 0.037 1.228 
PGIF 82.5% 0.016 441 
sEng 71.4% 0.113 * 
 
Various other studies also conducted bivariate 
statistics to look for cutoff values to help clinicians 
diagnose preeclampsia, with various cutoff values. 
Research by Chen (2009) has conducted an analysis 
of various previous studies to record the cut-off point 
score, although in this study it was found to be 
insignificant because it did not search for cut-off 
points, the study collected by Chen was Levine, 2006 
gestational age 13-20 weeks 7.9 ng/ml, 21-32 weeks 
7.2 ng/ml, 33-42 weeks 13.6 ng/ml; Salahuddin, 2007 
24.8 ng/ml; Bauman, 2008 5 ng/ml; and Stepan 2008 
4.14 ng/ml [27], [17], [28], [29].
 
Eremina et al., 2003 showed that glomerular 
capillary function was under VEGF control. That is 
when the level of VEGF in renal podocytes falls by 
50%, glomerular endothelial cells swell, the capillary 
loop collapses, and proteinuria develops as occurs in 
patients with preeclampsia [30].
 
In pregnant women of 22-24 weeks of 
gestation, diastolic notch findings in uterine arteries 
cannot predict the incidence of early-onset 
preeclampsia. PlGF levels can be a predictor of early 
onset preeclampsia. 
From this study an evaluation of the 
relationship between the variables on the incidence of 
early onset preeclampsia with the following results: a) 
the variables included in this study were maternal age, 
maternal body mass index, uterine arterial diastolic 
notch, pulsatility value of uterine artery index, PlGF 
levels, sEng; b) there were no significant differences 
between maternal age on the incidence of early onset 
preeclampsia; c) there were no significant differences 
between parity on the incidence of early onset 
preeclampsia; d) there was no significant difference 
between the maternal body mass index and the 
incidence of early onset preeclampsia; e) no 
significant differences were found between the 
presence or absence of uterine artery diastolic notch 
against the incidence of early onset preeclampsia; f) it 
was found a significant difference between the 
pulsatility value of the uterine artery index and the 
incidence of early onset preeclampsia; g) it was found 
that there were significant differences between PlGF 
levels and the incidence of early onset preeclampsia; 
h) no significant differences were found between sEng 
levels of the incidence of early onset preeclampsia. 
From this study we can conclude: a) value of 
the variable cut-off point was significant, namely 
pulsatility levels of the uterine artery index with 1.228 
cut-off points, Under Curve Area (AUC) 78.2% (95% 
IK 59.3%-97%), sensitivity 80%, specificity 64.6%; b) 
the value of the variable cut-off point is significant, 
namely PIGF levels with a 441 pg/ml cut-off point, 
Area Under Curve (AUC) of 82.5% (95% CI 61.5%-
100%), sensitivity 80%, specificity 87.7%; and c) 
pulsatility index of uterine artery and PlGF combined 
have 40% sensitivity and specificity 90.77%. 
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